share_log

MBX Biosciences | SC 13D: Statement of acquisition of beneficial ownership by individuals-OrbiMed Advisors LLC(12.0%),OrbiMed Capital GP VII LLC(9.9%), etc.

MBX Biosciences | SC 13D:超過5%持股股東披露文件-OrbiMed Advisors LLC(12.0%),OrbiMed Capital GP VII LLC(9.9%)等

美股SEC公告 ·  09/23 15:38
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息